Content area
Full Text
LONDON, Nov. 22, 2021 /PRNewswire-PRWeb/ -- With on-the-ground operations in both the United States and United Kingdom, Pasithea Therapeutics is working to bring treatments for depression and other mental health disorders to more people. Through a partnership with Zen Healthcare, Pasithea recently opened a clinic in the heart of Knightsbridge.
As reported by Benzinga, a study from the Canadian Rapid Treatment Centre of Excellence found that patients who used solely a Ketamine IV for anti-depression experienced higher response and remission rates than those who used both Ketamine and oral supplements. This has led to promising developments and new clinical trials being run on a number of new substances, like ketamine, to test for their use in treating mental health ailments like depression....